pimonidazole has been researched along with Hypopharyngeal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bos, C; Deckers, R; Geerts, WJC; Kok, RJ; Lammers, T; Moonen, CTW; Sadeghi, N; Storm, G; Zandvliet, M | 1 |
| Bussink, J; de Wilde, PC; Kaanders, JH; Marres, HA; Raleigh, JA; Rijken, PF; van den Hoogen, FJ; van der Kogel, AJ; Wijffels, KI | 1 |
2 other study(ies) available for pimonidazole and Hypopharyngeal Cancer
| Article | Year |
|---|---|
Hyperthermia-triggered release of hypoxic cell radiosensitizers from temperature-sensitive liposomes improves radiotherapy efficacy in vitro.
Topics: Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Dose-Response Relationship, Drug; Drug Compounding; Drug Stability; Humans; Hyperthermia, Induced; Hypopharyngeal Neoplasms; Liposomes; Nitroimidazoles; Radiation-Sensitizing Agents; Temperature | 2019 |
Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.
Topics: Aged; Biomarkers; Biopsy; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Laryngeal Neoplasms; Male; Microscopy, Fluorescence; Middle Aged; Nitroimidazoles; Oropharyngeal Neoplasms; Prognosis | 2000 |